Stockholm, June 15, 2017 — Nasdaq (Nasdaq: NDAQ) announced that Saniona AB (short name: SANION), a small cap company within the health care sector, has started trading of its shares on the main market of Nasdaq Stockholm. Saniona was previously listed on Nasdaq First North Premier and is the 54th company to list at Nasdaq’s Nordic markets* in 2017.
Saniona is a research and development company focused on drugs for diseases of the central nervous system, autoimmune diseases, metabolic diseases and treatment of pain. The company has a portfolio of potential drug candidates in pre-clinical and clinical stage including a Phase 3 program for obesity and two Phase 2 programs for metabolic disorders and cocaine addiction, respectively. The research is focused on ion channels – a unique protein class that enables and controls the passage of charged ions across cell membranes. Saniona is headquartered in Copenhagen, Denmark, and has ongoing collaboration agreements with a number of external research partners across the world. For more information, please visit www.saniona.com.
“Saniona has gone through a tremendous development since the first listing in 2014 on a junior market,” said Jørgen Drejer, CEO of Saniona. “We see increasing interest among institutional investors and buy side analysts. The new listing on Nasdaq Stockholm main market addresses this interest.”
“We welcome Saniona to the Nasdaq Stockholm main market,” said Adam Kostyál, SVP and Head of European listings at Nasdaq. “We are excited to see yet another company grow and transfer from Nasdaq First North to the main market, and we look forward to supporting Saniona for many years to come.”
*Main markets and Nasdaq First North at Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm.
Nasdaq (Nasdaq: NDAQ) is a leading global provider of trading, clearing, exchange technology, listing, information and public company services. Through its diverse portfolio of solutions, Nasdaq enables customers to plan, optimize and execute their business vision with confidence, using proven technologies that provide transparency and insight for navigating today's global capital markets. As the creator of the world's first electronic stock market, its technology powers more than 89 marketplaces in 50 countries, and 1 in 10 of the world's securities transactions. Nasdaq is home to 3,800 total listings with a market value of $11 trillion. To learn more, visit: http://business.nasdaq.com
Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland, Nasdaq Riga, Nasdaq Stockholm, Nasdaq Tallinn, Nasdaq Vilnius, Nasdaq Clearing and Nasdaq Broker Services are respectively brand names for the regulated markets of Nasdaq Copenhagen A/S, Nasdaq Helsinki Ltd., Nasdaq Iceland hf., Nasdaq Riga, AS, Nasdaq Stockholm AB, Nasdaq Tallinn AS, AB Nasdaq Vilnius, Nasdaq Clearing AB and Nasdaq Broker Services AB. Nasdaq Nordic represents the common offering by Nasdaq Copenhagen, Nasdaq Helsinki, Nasdaq Iceland and Nasdaq Stockholm. Nasdaq Baltic represents the common offering by Nasdaq Tallinn, Nasdaq Riga and Nasdaq Vilnius.
Cautionary Note Regarding Forward-Looking Statements
The matters described herein contain forward-looking statements that are made under the Safe Harbor provisions of the Private Securities Litigation Reform Act of 1995. These statements include, but are not limited to, statements about Nasdaq and its products and offerings. We caution that these statements are not guarantees of future performance. Actual results may differ materially from those expressed or implied in the forward-looking statements. Forward-looking statements involve a number of risks, uncertainties or other factors beyond Nasdaq's control. These factors include, but are not limited to factors detailed in Nasdaq's annual report on Form 10-K, and periodic reports filed with the U.S. Securities and Exchange Commission. We undertake no obligation to release any revisions to any forward-looking statements.
|Media Relations Contact|
|+46 73 449 78 07|